Title: वैकल्पिक

Text: Rifaximin is an oral non-systemic antibiotic, with minimal gastrointestinal absorption and broad-spectrum antibacterial activity covering both grampositive and gramnegative organisms. Rifaximin is currently worldwide used in patients with cirrhosis for preventing recurrent hepatic encephalopathy because its efficacy and safety has been proved by large randomized clinical trials. प्रत्येक पराग्राफले परीक्षण हुनेछ।

Save test: यदि तपाईं यो टाइपिङ परीक्षणलाई साझा गर्न चाहानुहुन्छ भने यो प्रयोग गर्नुहोस् (केवल प्रमाणीकृत प्रयोगकर्ताहरूको लागि)।